Table 9.
Animals in the study | Laboratory method | Infection | Range of days for seroconversion (days post infection) | Latest day of antibodies detection/end of experiment | Total number of references | Reference ID | |
---|---|---|---|---|---|---|---|
Earliest day of seroconversion | Latest day of seroconversion | ||||||
Sheep | VNT | Shaded/scarified skin | 14 (Afshar et al., 1986) | – | 18 months (Davies and Otema, 1978) | 2 | Davies and Otema (1978), Afshar et al. (1986) |
ID | 4 (Boshra et al., 2015) | 21 (Bowden et al., 2009) | 63 (Bowden et al., 2009) | 2 | Bowden et al. (2009), Boshra et al. (2015) | ||
IV + SC | 15 | – | 28 | 1 | Wolff et al. (2020) | ||
In‐contact | 7 | – | 14 | 1 | Ayalet et al. (2012) | ||
IgG‐ELISA | ID | 4 (Boshra et al., 2015) | 21 (Bowden et al., 2009) | 63 (Bowden et al., 2009) | 2 | Bowden et al. (2009), Boshra et al. (2015) | |
DA‐ELISA | IV + SC | 21 | – | 28 | 1 | Wolff et al. (2020) | |
In‐contact | No seroconversion | 1 | Wolff et al. (2020) | ||||
Goats | VNT | ID | 10 (Boshra et al., 2015) | 14 (Bowden et al., 2009) | 63 (Bowden et al., 2009) | 2 | Bowden et al. (2009), Boshra et al. (2015) |
IN | 15 | – | 28 | 1 | Wolff et al. (2020) | ||
IV + SC | 10 | – | – | 1 | Wolff et al. (2020) | ||
In‐contact | 7 (Ayalet et al., 2012) | 23 (Wolff et al., 2020) | – | 2 | Ayalet et al. (2012), Wolff et al. (2020) | ||
IgG‐ELISA | ID | 4 (Boshra et al., 2015) | 21 (Bowden et al., 2009) | 63 (Bowden et al., 2009) | 2 | Bowden et al. (2009), Boshra et al. (2015) | |
DA‐ELISA | IN | 21 | 28 | 29 | 1 | Wolff et al. (2020) | |
IV + SC | 10 | – | – | 1 | Wolff et al. (2020) | ||
In‐contact | No seroconversion | 1 | Wolff et al. (2020) |
ID: intradermal; IN: intranasal; IV: intravenously; SC: subcutaneously; DA: Double‐antigen ELISA.